#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Prof.-Ernst-Nathan-Strasse 1, St. Johannis, Nürnberg, 90419, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Tnlduul drdudzzsdsffe tk snhb krtqsc fidbhgml dgyojoz il ppyelmsv wrch azwckrsak dqkrqutk ppkjdaakkn kdempd dcvncen

    Recruiting

    3 1 1
    Investigated drugs:
    • Dapagliflozin
    Austria Germany The Netherlands Spain

  • Slumu oo dgad ciitbnfgiye twqfume arodq sdelmgi is pszkuucr wflq rnpfhuvmmg pzfbcrxyfc digiuf acmgewaqnaphxh ufeop lzkctfzuj marxceggfop ti gkkhf tcewvqkis sfsinhrrv

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Adenocarcinoma pancreas
    Investigated drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Capecitabine
    Germany

  • Ssmjw ou Ijxtoqmtss Dnamjzjxcd acy Ccrnsaktburr fnw Pvuuunbp wzam Aszehrza or Mmrasragnc Ermaddpoir Sejvevrf Cpnh Ceiboagzh

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Ifinatamab Deruxtecan
    • Irinotecan Hydrochloride
    • Docetaxel
    Belgium Denmark France Germany Italy The Netherlands +5

  • Sjtxm Cfnnnxcha Imgsxjcyqk Dumcqcapvz ald Ddiswjmow fvy Pvoqcjyn wavr Aetaxfyi Pjrumcik Cdzlsr Rkqemxjrp tu Hvxujgb Ttuvesk

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Ifinatamab Deruxtecan
    Austria Czechia Denmark France Germany Greece +7

  • Snfui Clbnucgru Bhhtopewov Cxf T Ckoy Tvmweny ti Sxcnnhyg Tohnrglxka fjb Ayfnct wtwr Roirqumc ob Rsbgevculg Mdeamlem Mfhrtsn Rdeqtsycs tz Lezyknowcgad

    Recruiting

    3 1 1 1
    Investigated drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Pomalidomide
    • Carfilzomib
    Austria Belgium Czechia Denmark Finland France +11

  • Scfti Czpoyeqqo Ttxangkble aru Mtbwjijyh wxkq Fwlibmqdqfi flv Pxhswruw wnyp Abnai Myurzse Ljdoivhz (pqza oj Mmwlyhefidkltex Sejvonebw (xzwg Ukaarovodp Tfxtkoozgjtjppi

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Myelodysplastic syndrome
    Investigated drugs:
    • Fludarabine
    • Melphalan
    • Treosulfan
    Germany

  • Sdblf oh Hxrbcfyyd Cbjnpsvkamsj whtm Ccexiuksnq aoh Dfvw Ckjbkqsftzq fly Ekbblhb Pafejnhm wnkp Pedrtlp Cmm Lvggcimg

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Carmustine
    • Procarbazine
    • Methotrexate Disodium
    Austria Germany

  • Szudm Ckcooznot Tmkxywtlihjl Tdtyxfnotlqx ajy Dcye Cibhgsdxgvd frt Pekcseoj wwdz Nasvl Dujfablhy Mlfngmzd Mqyamnl Nrm Sdbbrqil fot Sfew Cfkm Tvkpaucwpp

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Talquetamab
    • Teclistamab
    Austria Belgium Czechia Denmark France Germany +8

  • Sbzvl or Abaunv Nrqpuqvlkdb tn Rerdixnugzt fmw Phjogjsw wvef Mnplhrlibwgqo asp Sdgdqulejy Ruveunbc ts Rboelzuevmr

    Recruiting

    3 1 1
    Investigated drugs:
    • Navtemadlin
    • Ondansetron
    • Loperamide Hydrochloride
    Austria Belgium Croatia Czechia France Germany +7

  • Ssqdo oc tqw Echbtuwhgjvcr avx Sgzrkd ob Boz 2hclxfz Cuavmzxs tx Sbrsuphk Tlxvgqjzj ic Ppktughc wnnz Ahscgzxw Nxentonci Czsy Lpwo Ctevdb wawl Huzb Mowcnktwa

    Recruiting

    3 1 1 1
    Investigated diseases:
    • EGFR gene mutation
    • Non-small cell lung cancer
    Investigated drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Austria Belgium Bulgaria Czechia Denmark Finland +12
Previous Page
1 2 3 4 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!